This response is impaired in people with CF (pwCF) and is commonly used to assess CFTR modulator effects in vitro, enabling sensitive measurements of CFTR function and drug responsiveness while facilitating direct comparisons in PDIOs from pwCF. The gene discussed is CFTR; the disease is cystic fibrosis.